Cipla, Macleods HIV child treatments approved in South Africa
New Delhi: South Africa, which has the world's biggest number of people infected with HIV, has approved Cipla Ltd.'s quadrimune, a treatment for children infected with the virus, for use.
Quadrimune comes in the form of sweet-tasting granules that can be sprinkled on soft food or dissolved in mill or water, the South African Health Products Regulatory Authority said in a statement on Friday.
The treatment combines four antiretroviral treatments.
Read also: Cipla, DNDi unveil 4-in-1 ARV formulation for kids with HIV
Dolutegravir tablets, made by Macleods Pharmaceuticals Ltd., for the treatment of children with HIV, were also registered for use.
About 13% of South Africa's population, or 8.2 million people, are infected with HIV, according to the national statistics agency.
Read also: Cipla to purchase 21.05 percent stake in Achira Labs to develop affordable medical kits in India
